Skip to content

HQL

abrdn Life Sciences Investors

NYSE · Financial Services · Asset Management · US

$18.30
+0.97%
Ask drillr
Price chart
Oct 6Oct 9Oct 14Oct 19Oct 22Oct 27Oct 30Nov 4
Key dataNov 4, 2026
Open
$18.56
From 52W high
−19.30%
Volume
72275.00
Market cap
$528.22M
P/E (Fwd)
—
EV/EBITDA
6.2x
P/E (TTM)
6.2x
RSI (14)
48.2
1D Return
+0.97%
YTD Return
+7.63%
SummaryUpdated Mar 1, 2026

Tekla Life Sciences Investors (NYSE:HQL) is a closed-end investment fund that has been operating since 1992, making it one of the longest-running specialized life sciences investment vehicles in the public markets. Originally known as H&Q Life Sciences Investors, the fund was launched during the early boom years of biotechnology investing and has since evolved to become a focused player in the life sciences investment space. The fund is managed by Tekla Capital Management LLC and trades as a publicly listed closed-end fund, allowing individual and institutional investors to gain exposure to a diversified portfolio of life sciences companies through a single investment vehicle.

Similar companies

Latest newsMore news →

No recent news for HQL.